1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 1,2-dimethylhydrazine decreases expression ISO RGD:68660 6480464 1, 2-Dimethylhydrazine results in decreased expression of BHLHE40 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:68660 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BHLHE40 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of BHLHE40 mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BHLHE40 mRNA CTD PMID:30723492 15-acetyldeoxynivalenol increases expression ISO RGD:68659 6480464 15-acetyldeoxynivalenol results in increased expression of BHLHE40 mRNA CTD PMID:23792671 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BHLHE40 mRNA CTD PMID:15576828 more ... 17beta-estradiol increases expression ISO RGD:68660 6480464 Estradiol results in increased expression of BHLHE40 mRNA CTD PMID:15289156 , PMID:25210133 17beta-estradiol multiple interactions ISO RGD:68659 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of BHLHE40 mRNA, EGF protein inhibits the reaction [Estradiol results in decreased expression of BHLHE40 mRNA] CTD PMID:24758408 , PMID:30165855 17beta-estradiol decreases expression ISO RGD:68659 6480464 Estradiol results in decreased expression of BHLHE40 mRNA CTD PMID:16474171 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of BHLHE40 mRNA CTD PMID:20068009 17beta-estradiol increases expression ISO RGD:68659 6480464 Estradiol results in increased expression of BHLHE40 mRNA CTD PMID:19153601 , PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:68659 6480464 2 more ... CTD PMID:20638727 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:68659 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68659 6480464 Tetrachlorodibenzodioxin results in decreased expression of BHLHE40 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68660 6480464 Tetrachlorodibenzodioxin results in decreased expression of BHLHE40 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68660 6480464 Tetrachlorodibenzodioxin affects the expression of BHLHE40 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68660 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BHLHE40 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BHLHE40 mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BHLHE40 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:68660 6480464 Tetrachlorodibenzodioxin results in increased expression of BHLHE40 mRNA CTD PMID:16960034 , PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BHLHE40 mRNA CTD PMID:16960034 , PMID:33387578 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:68659 6480464 2 more ... CTD PMID:17547211 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of BHLHE40 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:68660 6480464 n-butoxyethanol results in increased expression of BHLHE40 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:68659 6480464 Lactic Acid results in increased expression of BHLHE40 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:68659 6480464 3 more ... CTD PMID:35618242 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:68659 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BHLHE40 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BHLHE40 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:68659 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BHLHE40 mRNA CTD PMID:28628672 4-hydroxynon-2-enal decreases expression ISO RGD:68660 6480464 4-hydroxy-2-nonenal results in decreased expression of BHLHE40 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:68660 6480464 Fenretinide results in increased expression of BHLHE40 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:68659 6480464 Fenretinide results in increased expression of BHLHE40 mRNA CTD PMID:15958647 5-aza-2'-deoxycytidine affects expression ISO RGD:68659 6480464 Decitabine affects the expression of BHLHE40 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BHLHE40 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of BHLHE40 mRNA CTD PMID:25825206 acetaldehyde increases expression ISO RGD:68659 6480464 Acetaldehyde results in increased expression of BHLHE40 mRNA CTD PMID:23416264 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of BHLHE40 mRNA CTD PMID:28959563 afimoxifene increases expression ISO RGD:68659 6480464 afimoxifene results in increased expression of BHLHE40 mRNA CTD PMID:16849584 , PMID:19153601 afimoxifene multiple interactions ISO RGD:68659 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of BHLHE40 mRNA] CTD PMID:19153601 aflatoxin B1 decreases methylation ISO RGD:68659 6480464 Aflatoxin B1 results in decreased methylation of BHLHE40 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BHLHE40 mRNA CTD PMID:33354967 all-trans-retinoic acid increases expression ISO RGD:68660 6480464 Tretinoin results in increased expression of BHLHE40 mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions ISO RGD:68660 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of BHLHE40 mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:68659 6480464 Tretinoin results in increased expression of BHLHE40 mRNA CTD PMID:15894607 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:68659 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of BHLHE40 mRNA CTD PMID:15894607 all-trans-retinoic acid affects expression ISO RGD:68659 6480464 Tretinoin affects the expression of BHLHE40 mRNA CTD PMID:15498508 amiodarone increases expression ISO RGD:68659 6480464 Amiodarone results in increased expression of BHLHE40 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BHLHE40 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:68659 6480464 aristolochic acid I results in decreased expression of BHLHE40 mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:68659 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of BHLHE40 mRNA CTD PMID:16934159 Aroclor 1254 increases expression ISO RGD:68660 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of BHLHE40 mRNA CTD PMID:25270620 arsane decreases response to substance ISO RGD:68659 6480464 BHLHE40 mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsenic atom decreases response to substance ISO RGD:68659 6480464 BHLHE40 mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsenite(3-) decreases methylation ISO RGD:68659 6480464 arsenite results in decreased methylation of BHLHE40 promoter CTD PMID:23974009 arsenite(3-) multiple interactions ISO RGD:68659 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of BHLHE40 mRNA CTD PMID:32076005 arsenous acid multiple interactions ISO RGD:68659 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of BHLHE40 mRNA CTD PMID:15894607 arsenous acid increases expression ISO RGD:68659 6480464 Arsenic Trioxide results in increased expression of BHLHE40 mRNA CTD PMID:15761015 atrazine increases expression ISO RGD:68659 6480464 Atrazine results in increased expression of BHLHE40 mRNA CTD PMID:22378314 Azaspiracid increases expression ISO RGD:68659 6480464 azaspiracid results in increased expression of BHLHE40 mRNA CTD PMID:28939011 benzo[a]pyrene decreases expression ISO RGD:68660 6480464 Benzo(a)pyrene results in decreased expression of BHLHE40 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:68659 6480464 Benzo(a)pyrene results in increased expression of BHLHE40 mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions ISO RGD:68660 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA CTD PMID:27858113 benzo[b]fluoranthene increases expression ISO RGD:68660 6480464 benzo(b)fluoranthene results in increased expression of BHLHE40 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:68660 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA CTD PMID:27858113 bis(2-ethylhexyl) phthalate increases expression ISO RGD:68659 6480464 Diethylhexyl Phthalate results in increased expression of BHLHE40 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:68659 6480464 bisphenol A results in decreased expression of BHLHE40 mRNA CTD PMID:16474171 bisphenol A increases expression ISO RGD:68659 6480464 bisphenol A results in increased expression of BHLHE40 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:68659 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BHLHE40 mRNA CTD PMID:28628672 bisphenol A affects methylation ISO RGD:68660 6480464 bisphenol A affects the methylation of BHLHE40 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BHLHE40 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:68660 6480464 bisphenol A results in increased expression of BHLHE40 mRNA CTD PMID:25270620 bisphenol F multiple interactions ISO RGD:68660 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of BHLHE40 mRNA CTD PMID:30951980 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of BHLHE40 mRNA CTD PMID:32479839 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of BHLHE40 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:68659 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of BHLHE40 mRNA CTD PMID:29432896 cadmium dichloride decreases expression ISO RGD:68659 6480464 Cadmium Chloride results in decreased expression of BHLHE40 mRNA CTD PMID:25596134 cadmium sulfate multiple interactions ISO RGD:68659 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of BHLHE40 mRNA CTD PMID:18654764 cadmium sulfate decreases expression ISO RGD:68659 6480464 cadmium sulfate results in decreased expression of BHLHE40 mRNA CTD PMID:21783983 captan increases expression ISO RGD:68660 6480464 Captan results in increased expression of BHLHE40 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:68659 6480464 Carbamazepine affects the expression of BHLHE40 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:68660 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:68660 6480464 Nanotubes, Carbon results in decreased expression of BHLHE40 mRNA CTD PMID:25620056 chloroacetaldehyde decreases expression ISO RGD:68659 6480464 chloroacetaldehyde results in decreased expression of BHLHE40 mRNA CTD PMID:25596134 chloropicrin affects expression ISO RGD:68659 6480464 chloropicrin affects the expression of BHLHE40 mRNA CTD PMID:26352163 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of BHLHE40 mRNA CTD PMID:23125180 chlorpromazine increases expression ISO RGD:68659 6480464 Chlorpromazine analog results in increased expression of BHLHE40 mRNA CTD PMID:15924885 chromium atom increases expression ISO RGD:68659 6480464 Chromium results in increased expression of BHLHE40 mRNA CTD PMID:17547211 chrysene multiple interactions ISO RGD:68660 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA CTD PMID:27858113 Cinobufagin increases expression ISO RGD:68659 6480464 cinobufagin results in increased expression of BHLHE40 mRNA CTD PMID:35447139 cisplatin decreases expression ISO RGD:68660 6480464 Cisplatin results in decreased expression of BHLHE40 mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:68659 6480464 Cisplatin results in increased expression of BHLHE40 mRNA CTD PMID:33545341 cisplatin affects expression ISO RGD:68659 6480464 Cisplatin affects the expression of BHLHE40 mRNA CTD PMID:23300844 clobetasol increases expression ISO RGD:68660 6480464 Clobetasol results in increased expression of BHLHE40 mRNA CTD PMID:27462272 clofibrate increases expression ISO RGD:68660 6480464 Clofibrate results in increased expression of BHLHE40 mRNA CTD PMID:25270620 cobalt dichloride multiple interactions ISO RGD:68659 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of BHLHE40 mRNA, zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BHLHE40 mRNA] CTD PMID:18654764 , PMID:22202117 cobalt dichloride increases expression ISO RGD:68659 6480464 cobaltous chloride results in increased expression of BHLHE40 mRNA CTD PMID:22202117 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of BHLHE40 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of BHLHE40 mRNA CTD PMID:20187946 copper atom decreases expression EXP 6480464 Copper results in decreased expression of BHLHE40 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of BHLHE40 mRNA CTD PMID:30556269 coumestrol multiple interactions ISO RGD:68659 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO RGD:68659 6480464 Coumestrol results in decreased expression of BHLHE40 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:68659 6480464 Asbestos, Crocidolite results in increased expression of BHLHE40 mRNA CTD PMID:18687144 , PMID:25351596 cyclosporin A increases expression ISO RGD:68659 6480464 Cyclosporine results in increased expression of BHLHE40 mRNA CTD PMID:20106945 more ... dexamethasone decreases expression ISO RGD:68660 6480464 Dexamethasone results in decreased expression of BHLHE40 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:68659 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BHLHE40 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BHLHE40 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:68659 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of BHLHE40 mRNA CTD PMID:15894607 diarsenic trioxide increases expression ISO RGD:68659 6480464 Arsenic Trioxide results in increased expression of BHLHE40 mRNA CTD PMID:15761015 dibenz[a,h]anthracene increases expression ISO RGD:68660 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:68660 6480464 Dibutyl Phthalate results in increased expression of BHLHE40 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BHLHE40 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO RGD:68660 6480464 Dichloroacetic Acid results in decreased expression of BHLHE40 mRNA CTD PMID:28962523 dichloromethane increases expression ISO RGD:68660 6480464 Methylene Chloride results in increased expression of BHLHE40 mRNA CTD PMID:28392392 diethylstilbestrol increases expression ISO RGD:68660 6480464 Diethylstilbestrol results in increased expression of BHLHE40 mRNA CTD PMID:15289156 dioxygen affects expression ISO RGD:68660 6480464 Oxygen deficiency affects the expression of BHLHE40 mRNA CTD PMID:17193925 dioxygen multiple interactions ISO RGD:68660 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE40 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:68659 6480464 Oxygen deficiency results in increased expression of BHLHE40 mRNA CTD PMID:20042640 more ... dioxygen increases expression ISO RGD:68660 6480464 Oxygen deficiency results in increased expression of BHLHE40 mRNA CTD PMID:20880076 dorsomorphin multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:68659 6480464 Doxorubicin results in decreased expression of BHLHE40 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:68659 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA CTD PMID:19167446 epoxiconazole decreases expression ISO RGD:68660 6480464 epoxiconazole results in decreased expression of BHLHE40 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:68659 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BHLHE40 mRNA, [Ethanol co-treated with Folic Acid] results in increased expression of BHLHE40 mRNA CTD PMID:23378141 , PMID:29432896 ethanol increases expression ISO RGD:68659 6480464 Ethanol results in increased expression of BHLHE40 mRNA CTD PMID:23378141 fenofibrate decreases expression ISO RGD:68659 6480464 Fenofibrate results in decreased expression of BHLHE40 mRNA CTD PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of BHLHE40 mRNA CTD PMID:25596134 ferric oxide increases expression ISO RGD:68660 6480464 ferric oxide analog results in increased expression of BHLHE40 mRNA CTD PMID:25086211 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of BHLHE40 mRNA CTD PMID:24793618 fluvastatin multiple interactions ISO RGD:68659 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of BHLHE40 mRNA CTD PMID:16996129 folic acid multiple interactions ISO RGD:68659 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of BHLHE40 mRNA, [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of BHLHE40 mRNA CTD PMID:23378141 , PMID:24657277 folic acid multiple interactions ISO RGD:68660 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BHLHE40 mRNA CTD PMID:22206623 folpet increases expression ISO RGD:68660 6480464 folpet results in increased expression of BHLHE40 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:68659 6480464 Formaldehyde results in increased expression of BHLHE40 mRNA CTD PMID:17938736 more ... furan decreases expression EXP 6480464 furan results in decreased expression of BHLHE40 mRNA CTD PMID:25539665 , PMID:26194646 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of BHLHE40 mRNA CTD PMID:17785943 genistein decreases expression ISO RGD:68659 6480464 Genistein results in decreased expression of BHLHE40 mRNA CTD PMID:16474171 genistein increases expression ISO RGD:68660 6480464 Genistein results in increased expression of BHLHE40 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BHLHE40 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of BHLHE40 mRNA CTD PMID:24136188 glycine betaine increases expression EXP 6480464 Betaine results in increased expression of BHLHE40 mRNA CTD PMID:26391144 Heptachlor epoxide increases expression ISO RGD:68660 6480464 Heptachlor Epoxide results in increased expression of BHLHE40 mRNA CTD PMID:25270620 hypochlorous acid decreases expression ISO RGD:68660 6480464 Hypochlorous Acid results in decreased expression of BHLHE40 mRNA CTD PMID:19376150 ifosfamide increases expression ISO RGD:68659 6480464 Ifosfamide results in increased expression of BHLHE40 mRNA CTD PMID:25596134 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of BHLHE40 mRNA CTD PMID:21396975 indometacin increases expression ISO RGD:68659 6480464 Indomethacin results in increased expression of BHLHE40 mRNA CTD PMID:16984733 indometacin multiple interactions ISO RGD:68659 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BHLHE40 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BHLHE40 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO RGD:68659 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BHLHE40 mRNA CTD PMID:29432896 isotretinoin increases expression ISO RGD:68659 6480464 Isotretinoin results in increased expression of BHLHE40 mRNA CTD PMID:18769122 ketamine increases expression EXP 6480464 Ketamine results in increased expression of BHLHE40 mRNA CTD PMID:20080153 lead(0) affects expression ISO RGD:68659 6480464 Lead affects the expression of BHLHE40 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:68659 6480464 Lead affects the expression of BHLHE40 mRNA CTD PMID:28903495 lead(II) chloride multiple interactions ISO RGD:68659 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of BHLHE40 mRNA CTD PMID:18654764 leflunomide increases expression ISO RGD:68659 6480464 leflunomide results in increased expression of BHLHE40 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of BHLHE40 mRNA] CTD PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:68659 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BHLHE40 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:68659 6480464 Lipopolysaccharides results in increased expression of BHLHE40 mRNA CTD PMID:35811015 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of BHLHE40 mRNA CTD PMID:16415329 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of BHLHE40 mRNA CTD PMID:28801915 mercury atom increases expression ISO RGD:68659 6480464 Mercury results in increased expression of BHLHE40 mRNA CTD PMID:17547211 , PMID:19937285 mercury dibromide increases expression ISO RGD:68659 6480464 mercuric bromide results in increased expression of BHLHE40 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA CTD PMID:27188386 mercury(0) increases expression ISO RGD:68659 6480464 Mercury results in increased expression of BHLHE40 mRNA CTD PMID:17547211 , PMID:19937285 metformin affects expression EXP 6480464 Metformin affects the expression of BHLHE40 mRNA CTD PMID:25596134 methidathion decreases expression ISO RGD:68660 6480464 methidathion results in decreased expression of BHLHE40 mRNA CTD PMID:34813904 methotrexate multiple interactions ISO RGD:68659 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of BHLHE40 mRNA CTD PMID:24657277 methotrexate increases expression ISO RGD:68659 6480464 Methotrexate results in increased expression of BHLHE40 mRNA CTD PMID:24657277 methoxsalen multiple interactions ISO RGD:68659 6480464 BHLHE40 protein inhibits the reaction [Methoxsalen results in decreased expression of BIRC5 protein], BHLHE40 protein inhibits the reaction [Methoxsalen results in increased activity of and results in decreased expression of CASP3 protein] CTD PMID:22796345 methoxsalen decreases expression ISO RGD:68659 6480464 Methoxsalen results in decreased expression of BHLHE40 mRNA, Methoxsalen results in decreased expression of BHLHE40 protein CTD PMID:22796345 methoxsalen decreases response to substance ISO RGD:68659 6480464 BHLHE40 protein results in decreased susceptibility to Methoxsalen CTD PMID:22796345 methylmercury chloride decreases expression ISO RGD:68659 6480464 methylmercuric chloride results in decreased expression of BHLHE40 mRNA CTD PMID:23179753 methylmercury chloride increases expression ISO RGD:68659 6480464 methylmercuric chloride results in increased expression of BHLHE40 mRNA CTD PMID:28001369 methylparaben increases expression ISO RGD:68659 6480464 methylparaben results in increased expression of BHLHE40 mRNA CTD PMID:31745603 N-methyl-4-phenylpyridinium decreases expression ISO RGD:68660 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BHLHE40 mRNA CTD PMID:17475336 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of BHLHE40 mRNA] CTD PMID:16415329 nickel sulfate increases expression ISO RGD:68659 6480464 nickel sulfate results in increased expression of BHLHE40 mRNA CTD PMID:18651567 , PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of BHLHE40 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BHLHE40 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of BHLHE40 mRNA CTD PMID:28623178 ozone multiple interactions ISO RGD:68660 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BHLHE40 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of BHLHE40 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:68659 6480464 p-Chloromercuribenzoic Acid results in increased expression of BHLHE40 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:68659 6480464 panobinostat results in increased expression of BHLHE40 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:68659 6480464 Acetaminophen results in increased expression of BHLHE40 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BHLHE40 mRNA CTD PMID:32680482 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of BHLHE40 mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:68660 6480464 Phenobarbital results in increased expression of BHLHE40 mRNA CTD PMID:19270015 phenol increases expression ISO RGD:68659 6480464 Phenol results in increased expression of BHLHE40 mRNA CTD PMID:17547211 phenylmercury acetate increases expression ISO RGD:68659 6480464 Phenylmercuric Acetate results in increased expression of BHLHE40 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:68660 6480464 Phosgene affects the expression of BHLHE40 mRNA CTD PMID:16300373 pirinixic acid increases expression ISO RGD:68660 6480464 pirinixic acid results in increased expression of BHLHE40 mRNA CTD PMID:18445702 pirinixic acid decreases expression ISO RGD:68660 6480464 pirinixic acid results in decreased expression of BHLHE40 mRNA CTD PMID:23811191 potassium chromate decreases expression ISO RGD:68659 6480464 potassium chromate(VI) results in decreased expression of BHLHE40 mRNA CTD PMID:22714537 potassium dichromate increases expression ISO RGD:68659 6480464 Potassium Dichromate results in increased expression of BHLHE40 mRNA CTD PMID:17547211 progesterone increases expression ISO RGD:68659 6480464 Progesterone results in increased expression of BHLHE40 mRNA CTD PMID:18037150 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of BHLHE40 mRNA CTD PMID:18095365 quercetin increases expression ISO RGD:68659 6480464 Quercetin results in increased expression of BHLHE40 mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:68659 6480464 Oxyquinoline results in decreased expression of BHLHE40 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:68659 6480464 Lactic Acid results in increased expression of BHLHE40 mRNA CTD PMID:30851411 ranitidine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of BHLHE40 mRNA] CTD PMID:16415329 resorcinol increases expression ISO RGD:68659 6480464 resorcinol results in increased expression of BHLHE40 mRNA CTD PMID:22623647 resveratrol multiple interactions ISO RGD:68659 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of BHLHE40 mRNA CTD PMID:19167446 rifampicin multiple interactions ISO RGD:68659 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of BHLHE40 mRNA CTD PMID:21127053 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BHLHE40 mRNA CTD PMID:27900601 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of BHLHE40 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68659 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BHLHE40 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:68660 6480464 Silicon Dioxide results in increased expression of BHLHE40 mRNA CTD PMID:19073995 more ... silicon dioxide increases expression ISO RGD:68659 6480464 Silicon Dioxide results in increased expression of BHLHE40 mRNA CTD PMID:25351596 silver atom decreases expression ISO RGD:68660 6480464 Silver results in decreased expression of BHLHE40 mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:68659 6480464 Silver results in increased expression of BHLHE40 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:68660 6480464 Silver results in decreased expression of BHLHE40 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:68659 6480464 Silver results in increased expression of BHLHE40 mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:68660 6480464 sodium arsenite results in decreased expression of BHLHE40 mRNA CTD PMID:25270620 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BHLHE40 mRNA CTD PMID:35314868 sodium arsenite multiple interactions ISO RGD:68659 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of BHLHE40 mRNA CTD PMID:32076005 sodium dichromate increases expression ISO RGD:68660 6480464 sodium bichromate results in increased expression of BHLHE40 mRNA CTD PMID:31558096 styrene increases expression ISO RGD:68660 6480464 Styrene results in increased expression of BHLHE40 mRNA CTD PMID:28951217 sulforaphane increases expression ISO RGD:68659 6480464 sulforaphane results in increased expression of BHLHE40 mRNA CTD PMID:26833863 sunitinib increases expression ISO RGD:68659 6480464 Sunitinib results in increased expression of BHLHE40 mRNA CTD PMID:31533062 tamibarotene affects expression ISO RGD:68659 6480464 tamibarotene affects the expression of BHLHE40 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:68659 6480464 Tamoxifen affects the expression of BHLHE40 mRNA CTD PMID:14699072 testosterone increases expression ISO RGD:68659 6480464 Testosterone results in increased expression of BHLHE40 mRNA CTD PMID:33359661 tetraphene multiple interactions ISO RGD:68660 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA CTD PMID:27858113 thapsigargin decreases expression ISO RGD:68659 6480464 Thapsigargin results in decreased expression of BHLHE40 mRNA CTD PMID:22378314 thimerosal decreases expression ISO RGD:68659 6480464 Thimerosal results in decreased expression of BHLHE40 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BHLHE40 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:68660 6480464 titanium dioxide results in increased expression of BHLHE40 mRNA CTD PMID:23409001 , PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BHLHE40 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of BHLHE40 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BHLHE40 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:68659 6480464 trichostatin A results in increased expression of BHLHE40 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:68659 6480464 trichostatin A affects the expression of BHLHE40 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:68659 6480464 Triclosan results in increased expression of BHLHE40 mRNA CTD PMID:30510588 Triptolide decreases expression ISO RGD:68660 6480464 triptolide results in decreased expression of BHLHE40 mRNA CTD PMID:32835833 triptonide decreases expression ISO RGD:68660 6480464 triptonide results in decreased expression of BHLHE40 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:68659 6480464 troglitazone results in decreased expression of BHLHE40 mRNA CTD PMID:25572481 trovafloxacin multiple interactions ISO RGD:68660 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BHLHE40 mRNA CTD PMID:18930950 tunicamycin decreases expression ISO RGD:68659 6480464 Tunicamycin results in decreased expression of BHLHE40 mRNA CTD PMID:22378314 undecane increases expression EXP 6480464 undecane results in increased expression of BHLHE40 protein CTD PMID:17337753 urethane decreases expression ISO RGD:68659 6480464 Urethane results in decreased expression of BHLHE40 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:68660 6480464 Valproic Acid affects the expression of BHLHE40 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:68659 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:68659 6480464 Valproic Acid results in increased expression of BHLHE40 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:68659 6480464 Valproic Acid results in decreased methylation of BHLHE40 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:68659 6480464 Valproic Acid affects the expression of BHLHE40 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:68659 6480464 Valproic Acid results in decreased expression of BHLHE40 mRNA CTD PMID:19949822 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of BHLHE40 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of BHLHE40 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:68659 6480464 vorinostat results in decreased expression of BHLHE40 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:68659 6480464 vorinostat results in increased expression of BHLHE40 mRNA CTD PMID:26272509 Yessotoxin increases expression ISO RGD:68659 6480464 yessotoxin analog results in increased expression of BHLHE40 mRNA CTD PMID:30679557 zinc dichloride multiple interactions ISO RGD:68659 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BHLHE40 mRNA] CTD PMID:22202117 zoledronic acid multiple interactions ISO RGD:68659 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of BHLHE40 mRNA CTD PMID:16996129